Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03473406

Ligand	Ligand name	Chain	PDB	Tanimoto
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.7
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.77
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.77
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.77
EAH	(5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid	A	3DZT	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.71
0MA	maslinic acid	A	2QN2	0.7
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.71
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.73
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.82
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.74
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.74
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.74
0AS	asiatic acid	A	2QN1	0.7
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.81
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.7
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.74
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.73
RCL	RICINOLEIC ACID	A	2CM4	0.78
RCL	RICINOLEIC ACID	A	2CM9	0.78
RCL	RICINOLEIC ACID	A	1FK7	0.78
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.71
ASY	(12E)-10-oxooctadec-12-enoic acid	A,B	3CEE	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.71
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.71
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.72
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A,B	2ZK1	0.71
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A	2ZK2	0.71
GMM	GLUCOSE MONOMYCOLATE	A	1UQS	0.71
RGC	REIDISPONGIOLIDE C	A	2ASP	0.72
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.72
114	COMPACTIN	A,B,C,D	1HW8	0.72
803	LOVASTATIN	A,B	1CQP	0.72
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.71
DEX	DEXAMETHASONE	A,D	1M2Z	0.71
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.71
1NB	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	P	1BRU	0.73
E2P	PROSTAGLANDIN B2	A	1CZ2	0.72
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.72
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.76
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.71
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.71
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.71
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.72
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.72
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.72
AXT	ASTAXANTHIN	A,B	1GKA	0.7
TES	TESTOSTERONE	A	1JTV	0.71
TES	TESTOSTERONE	A	2Q7L	0.71
TES	TESTOSTERONE	A	2Q7I	0.71
TES	TESTOSTERONE	A,B	1J96	0.71
TES	TESTOSTERONE	A	2Q7K	0.71
TES	TESTOSTERONE	A,B	1Q13	0.71
TES	TESTOSTERONE	H	1I9J	0.71
TES	TESTOSTERONE	A,B	1AFS	0.71
TES	TESTOSTERONE	H	1VPO	0.71
TES	TESTOSTERONE	A	2Q7J	0.71
TES	TESTOSTERONE	A,B	3BUR	0.71
TES	TESTOSTERONE	A	2AM9	0.71
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.71
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.71
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.71
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.71
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.71
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.89
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.89
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.71
MRC	MUPIROCIN	A	1JZS	0.73
MRC	MUPIROCIN	A,T	1FFY	0.73
MRC	MUPIROCIN	A	1QU3	0.73
MRC	MUPIROCIN	A,T	1QU2	0.73
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.85
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.86
MVB	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	A,B,C	1YA8	0.71
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.89
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.76